Search research articles
Contact Us
Filters
Showing results (91-100 of 110) with videos related to
Page
of 11
Sort By:
JAMA Oncology
|
April 14, 2022
Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy: The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial
Eric Leung, Adam P Gladwish, Melanie Davidson, et al.
Gynecologic Oncology
|
April 11, 2024
Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016
Lilian T Gien, Danielle M Enserro, Matthew S Block, et al.
Cancer
|
October 21, 2015
Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative
Farzana Pashankar, Juliet P Hale, Ha Dang, et al.
Gynecologic Oncology
|
March 9, 2025
Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278)
Jeanne Carter, Helen Q Huang, Bradley J Monk, et al.
Gynecologic Oncology
|
June 10, 2018
Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
Rachana Shah, Caihong Xia, Mark Krailo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 24, 2026
The International Gynecologic Cancer Society Global Fellowship Program: advancing access to gynecologic oncology and surgical care worldwide
Parisa N Fallah, Anisa Mburu, Ricardina Rangeiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2011
Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer
Beth Y Karlan, Amit M Oza, Gary E Richardson, et al.
Gynecologic Oncology
|
March 8, 2025
Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278)
Allan Covens, Helen Q Huang, Bradley J Monk, et al.
The New England Journal of Medicine
|
July 3, 2024
Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer
Ignace Vergote, Antonio González-Martín, Keiichi Fujiwara, et al.
Gynecologic Oncology
|
January 24, 2020
Low-grade serous ovarian cancer: State of the science
Brian Slomovitz, Charlie Gourley, Mark S Carey, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 110) with videos related to
Sort By:
Page
of 11
JAMA Oncology
|
April 14, 2022
Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy: The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial
Eric Leung, Adam P Gladwish, Melanie Davidson, et al.
Gynecologic Oncology
|
April 11, 2024
Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016
Lilian T Gien, Danielle M Enserro, Matthew S Block, et al.
Cancer
|
October 21, 2015
Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative
Farzana Pashankar, Juliet P Hale, Ha Dang, et al.
Gynecologic Oncology
|
March 9, 2025
Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278)
Jeanne Carter, Helen Q Huang, Bradley J Monk, et al.
Gynecologic Oncology
|
June 10, 2018
Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
Rachana Shah, Caihong Xia, Mark Krailo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 24, 2026
The International Gynecologic Cancer Society Global Fellowship Program: advancing access to gynecologic oncology and surgical care worldwide
Parisa N Fallah, Anisa Mburu, Ricardina Rangeiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2011
Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer
Beth Y Karlan, Amit M Oza, Gary E Richardson, et al.
Gynecologic Oncology
|
March 8, 2025
Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278)
Allan Covens, Helen Q Huang, Bradley J Monk, et al.
The New England Journal of Medicine
|
July 3, 2024
Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer
Ignace Vergote, Antonio González-Martín, Keiichi Fujiwara, et al.
Gynecologic Oncology
|
January 24, 2020
Low-grade serous ovarian cancer: State of the science
Brian Slomovitz, Charlie Gourley, Mark S Carey, et al.
Page
of 11